OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
Emire Seyahi, Guldaran Bakhdiyarli, Mert Öztaş, et al.
Rheumatology International (2021) Vol. 41, Iss. 8, pp. 1429-1440
Open Access | Times Cited: 89
Emire Seyahi, Guldaran Bakhdiyarli, Mert Öztaş, et al.
Rheumatology International (2021) Vol. 41, Iss. 8, pp. 1429-1440
Open Access | Times Cited: 89
Showing 26-50 of 89 citing articles:
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies
Chao Zhang, Yuqiang Zhang, Run-Ben Liu, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Chao Zhang, Yuqiang Zhang, Run-Ben Liu, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Antibody response to two doses of inactivated SARS‐CoV‐2 vaccine (CoronaVac) in kidney transplant recipients
Rezzan Eren Sadioğlu, Erol Demir, Ebru Evren, et al.
Transplant Infectious Disease (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 30
Rezzan Eren Sadioğlu, Erol Demir, Ebru Evren, et al.
Transplant Infectious Disease (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 30
Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine
Ayşe Özdede, Sabriye Güner, Guzin Ozcifci, et al.
Rheumatology International (2022) Vol. 42, Iss. 6, pp. 973-987
Open Access | Times Cited: 21
Ayşe Özdede, Sabriye Güner, Guzin Ozcifci, et al.
Rheumatology International (2022) Vol. 42, Iss. 6, pp. 973-987
Open Access | Times Cited: 21
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
Victoria Furer, Tali Eviatar, Devy Zisman, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 901-901
Open Access | Times Cited: 21
Victoria Furer, Tali Eviatar, Devy Zisman, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 901-901
Open Access | Times Cited: 21
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, et al.
EBioMedicine (2023) Vol. 91, pp. 104563-104563
Open Access | Times Cited: 11
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, et al.
EBioMedicine (2023) Vol. 91, pp. 104563-104563
Open Access | Times Cited: 11
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19
Sabrina Clever, Lisa-Marie Schünemann, Federico Armando, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 52-52
Open Access | Times Cited: 4
Sabrina Clever, Lisa-Marie Schünemann, Federico Armando, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 52-52
Open Access | Times Cited: 4
Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis
Lei Zhang, Lihong Jiang, Tian Tian, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 33-33
Open Access | Times Cited: 18
Lei Zhang, Lihong Jiang, Tian Tian, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 33-33
Open Access | Times Cited: 18
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons
Karim Yaqub Ibrahim, R. Moreira, C. Santos, et al.
Revista do Instituto de Medicina Tropical de São Paulo (2024)
Open Access | Times Cited: 3
Karim Yaqub Ibrahim, R. Moreira, C. Santos, et al.
Revista do Instituto de Medicina Tropical de São Paulo (2024)
Open Access | Times Cited: 3
Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity
Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2079-2089
Open Access | Times Cited: 12
Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2079-2089
Open Access | Times Cited: 12
COVID-19 Vaccines—All You Want to Know
Akira Shishido, Ashley H. Barnes, Shivakumar Narayanan, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 143-172
Closed Access | Times Cited: 7
Akira Shishido, Ashley H. Barnes, Shivakumar Narayanan, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 143-172
Closed Access | Times Cited: 7
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis
Sonphet Chirasuthat, Yanisa Ratanapokasatit, Kunlawat Thadanipon, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40009-adv40009
Open Access | Times Cited: 2
Sonphet Chirasuthat, Yanisa Ratanapokasatit, Kunlawat Thadanipon, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40009-adv40009
Open Access | Times Cited: 2
Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
Chutima Seree-aphinan, Kumutnart Chanprapaph, Ploysyne Rattanakaemakorn, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Chutima Seree-aphinan, Kumutnart Chanprapaph, Ploysyne Rattanakaemakorn, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2089-2096
Open Access | Times Cited: 11
Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2089-2096
Open Access | Times Cited: 11
Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force
Anna Carolina Faria Moreira Gomes Tavares, Ana Karla Guedes de Melo, Vítor Alves Cruz, et al.
Advances in Rheumatology (2022) Vol. 62, Iss. 1
Open Access | Times Cited: 10
Anna Carolina Faria Moreira Gomes Tavares, Ana Karla Guedes de Melo, Vítor Alves Cruz, et al.
Advances in Rheumatology (2022) Vol. 62, Iss. 1
Open Access | Times Cited: 10
Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs
Neşe Saltoğlu, Harika Öykü Dinç, İ̇lker İnanç Balkan, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 104, Iss. 2, pp. 115758-115758
Open Access | Times Cited: 10
Neşe Saltoğlu, Harika Öykü Dinç, İ̇lker İnanç Balkan, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 104, Iss. 2, pp. 115758-115758
Open Access | Times Cited: 10
Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
Huiqiong Zeng, Hanjiang Liu, Zhi Liu, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 9
Huiqiong Zeng, Hanjiang Liu, Zhi Liu, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 9
Immunogenicity of COVID ‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta‐analysis
Maysoon Al‐Haideri, Talar Ahmad Merza Mohammad, Shahram Darvishzadehdeldari, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 7, pp. 1227-1234
Closed Access | Times Cited: 5
Maysoon Al‐Haideri, Talar Ahmad Merza Mohammad, Shahram Darvishzadehdeldari, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 7, pp. 1227-1234
Closed Access | Times Cited: 5
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
Hüseyin Bilgin, Marisa Marku, Sultan Seval Yılmaz, et al.
Vaccine (2022) Vol. 40, Iss. 18, pp. 2619-2625
Open Access | Times Cited: 8
Hüseyin Bilgin, Marisa Marku, Sultan Seval Yılmaz, et al.
Vaccine (2022) Vol. 40, Iss. 18, pp. 2619-2625
Open Access | Times Cited: 8
A Case Report and Literature Review of a Triple-Vaccinated, Rituximab-Treated Systemic Lupus Erythematosus patient with COVID-19 pneumonia
Christos Michailides, Themistoklis Paraskevas, Maria Lagadinou, et al.
ARP Rheumatology (2024) Vol. 3, Iss. 2, pp. 145-150
Open Access | Times Cited: 1
Christos Michailides, Themistoklis Paraskevas, Maria Lagadinou, et al.
ARP Rheumatology (2024) Vol. 3, Iss. 2, pp. 145-150
Open Access | Times Cited: 1
Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals
Amy May Lin Quek, Suqing Wang, Ooiean Teng, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106238-106238
Closed Access | Times Cited: 1
Amy May Lin Quek, Suqing Wang, Ooiean Teng, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106238-106238
Closed Access | Times Cited: 1
Antibody response dynamics to CoronaVac vaccine and booster immunization in adults and the elderly: A long-term, longitudinal prospective study
Gustavo Jardim Volpe, Sandra Coccuzzo Sampaio Vessoni, Lais Braga Soares, et al.
IJID Regions (2023) Vol. 7, pp. 222-229
Open Access | Times Cited: 4
Gustavo Jardim Volpe, Sandra Coccuzzo Sampaio Vessoni, Lais Braga Soares, et al.
IJID Regions (2023) Vol. 7, pp. 222-229
Open Access | Times Cited: 4
Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with Obesity
Zehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Obesity Facts (2023) Vol. 16, Iss. 4, pp. 374-380
Open Access | Times Cited: 4
Zehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Obesity Facts (2023) Vol. 16, Iss. 4, pp. 374-380
Open Access | Times Cited: 4
Recent Advances in Understanding COVID-19 Pathophysiology and Therapy: A Review
Imran Rashid Rangraze, Malay Jhancy, Shehla Khan
(2023)
Open Access | Times Cited: 4
Imran Rashid Rangraze, Malay Jhancy, Shehla Khan
(2023)
Open Access | Times Cited: 4
